Advertisement
ARAY vs INMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Buy and INMD is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ARAY’s FA Score shows that 0 FA rating(s) are green whileINMD’s FA Score has 0 green FA rating(s).
- ARAY’s FA Score: 0 green, 5 red.
- INMD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ARAY’s TA Score shows that 4 TA indicator(s) are bullish while INMD’s TA Score has 4 bullish TA indicator(s).
- ARAY’s TA Score: 4 bullish, 4 bearish.
- INMD’s TA Score: 4 bullish, 5 bearish.
Price Growth
ARAY (@Medical/Nursing Services) experienced а -4.02% price change this week, while INMD (@Medical/Nursing Services) price change was -2.57% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +9.32%.
Reported Earning Dates
ARAY is expected to report earnings on Oct 29, 2025.
INMD is expected to report earnings on Oct 22, 2025.
Industries' Descriptions
@Medical/Nursing Services (-2.15% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ARAY | INMD | ARAY / INMD | |
| Capitalization | 188M | 934M | 20% |
| EBITDA | 20.2M | 115M | 18% |
| Gain YTD | -15.657 | -11.497 | 136% |
| P/E Ratio | N/A | 6.21 | - |
| Revenue | 459M | 402M | 114% |
| Total Cash | 57.4M | 511M | 11% |
| Total Debt | 176M | 6.1M | 2,884% |
ARAY | INMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 75 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 58 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 92 | 37 | |
PRICE GROWTH RATING 1..100 | 45 | 60 | |
P/E GROWTH RATING 1..100 | 40 | 85 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
INMD's Valuation (58) in the null industry is in the same range as ARAY (85) in the Medical Specialties industry. This means that INMD’s stock grew similarly to ARAY’s over the last 12 months.
INMD's Profit vs Risk Rating (100) in the null industry is in the same range as ARAY (100) in the Medical Specialties industry. This means that INMD’s stock grew similarly to ARAY’s over the last 12 months.
INMD's SMR Rating (37) in the null industry is somewhat better than the same rating for ARAY (92) in the Medical Specialties industry. This means that INMD’s stock grew somewhat faster than ARAY’s over the last 12 months.
ARAY's Price Growth Rating (45) in the Medical Specialties industry is in the same range as INMD (60) in the null industry. This means that ARAY’s stock grew similarly to INMD’s over the last 12 months.
ARAY's P/E Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for INMD (85) in the null industry. This means that ARAY’s stock grew somewhat faster than INMD’s over the last 12 months.
| ARAY | INMD | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 79% | N/A |
| Stochastic ODDS (%) | 1 day ago 78% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 70% |
| MACD ODDS (%) | 1 day ago 82% | 1 day ago 68% |
| TrendWeek ODDS (%) | 1 day ago 81% | 1 day ago 76% |
| TrendMonth ODDS (%) | 1 day ago 75% | 1 day ago 77% |
| Advances ODDS (%) | 18 days ago 76% | 11 days ago 76% |
| Declines ODDS (%) | 24 days ago 80% | 17 days ago 77% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 70% | 1 day ago 76% |
Advertisement
ARAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with ILMN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then ILMN could also see price increases.
| Ticker / NAME | Correlation To ARAY | 1D Price Change % | ||
|---|---|---|---|---|
| ARAY | 100% | -5.65% | ||
| ILMN - ARAY | 41% Loosely correlated | -2.35% | ||
| A - ARAY | 41% Loosely correlated | -2.00% | ||
| INMD - ARAY | 40% Loosely correlated | -1.14% | ||
| ITGR - ARAY | 40% Loosely correlated | -1.17% | ||
| GKOS - ARAY | 40% Loosely correlated | -1.59% | ||
More | ||||